Ranitidine and Mucomyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Mucomyst (acetylcysteine). Common drug interactions include eating disorder among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Mucomyst. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

On Aug, 02, 2026

26 people who take Ranitidine and Mucomyst together, and have interactions are studied.

Ranitidine and Mucomyst drug interactions.

What are the common drug interactions of Ranitidine and Mucomyst, by gender? *:

female:

Eating disorder
Ejection fraction decreased (systolic heart failure)
Electrocardiogram st segment elevation
Electrocardiogram st-t change
Exercise tolerance decreased
Fatigue (feeling of tiredness)
Flatulence (flatus expelled through the anus)
Foot fracture
Haematochezia (passage of stools containing blood)
Haemoglobin decreased

male:

Cardiac failure
Pain in extremity
Dry mouth
Ejection fraction decreased (systolic heart failure)
Febrile neutropenia (fever with reduced white blood cells)
Fibrin d dimer increased
Pulmonary embolism (blockage of the main artery of the lung)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Weight increased
Abdominal pain

What are the common drug interactions of Ranitidine and Mucomyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Exercise tolerance decreased
Pneumonia
Weight decreased

40-49:

Asthenia (weakness)
Back pain
Blood pressure decreased
Cellulitis (infection under the skin)
Chest pain
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Coagulopathy (blood's ability to clot is impaired)
Confusional state
Decreased appetite
Dehydration (dryness resulting from the removal of water)

50-59:

Alveolitis allergic (inflammation of the alveoli within the lung caused by hypersensitivity to inhaled organic dusts)
Cardiac valve disease (heart valve disease)
Dry mouth
Ejection fraction decreased (systolic heart failure)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Weight increased
Cardiac failure

60+:

Anaemia (lack of blood)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cerebral atrophy (decrement in size of brain)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
Constipation
Cystitis (inflammation of the wall of the bladder)
Dehydration (dryness resulting from the removal of water)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 7 people, 26.92%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 4 people, 15.38%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 3 people, 11.54%
Renal Impairment (severely reduced kidney function): 3 people, 11.54%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 7.69%
Gout (uric acid crystals building up in the body): 2 people, 7.69%
Agitation (state of anxiety or nervous excitement): 2 people, 7.69%
Arrhythmias (irregular heartbeat): 2 people, 7.69%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 7.69%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Mucomyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously